Role of the Nrf2 signaling system in health and disease
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
A key component of cytoprotective gene regulation is the transcription factor nuclear factor erythroid 2‐related factor 2 (Nrf2), also known as nuclear factor erythroid 2‐like 2, from the gene NFE2L2. Under normal conditions, Nrf2 in the cell is targeted for proteasomal degradation by its inhibitor Kelch‐like ECH‐associated inhibitor 1 (Keap1). When stimulated by oxidative stress, electrophiles, or kinase activation, conformational changes in the Nrf2‐Keap1 complex inhibit proteasomal degradation of Nrf2, facilitating an increase in the amount of Nrf2 that binds to antioxidant response element sequences in the promoter regions of a variety of antioxidant, detoxification, and metabolic control genes. Nrf2 activation is mostly associated with beneficial cytoprotective gene regulation, but it can also have deleterious effects. For example, gene mutations in some types of cancers can lead to constitutive activation of Nrf2 and give the tumor cells growth advantages and increased drug resistance. Because cases exist where Nrf2/Keap1/ARE signaling is either too low or too high, there is great interest in the development of both Nrf2 activators and Nrf2 inhibitors as the basis of new therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Nrf2–Keap1 defines a physiologically important stress response mechanism
Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725 · cited 1×
“Physiol Genomics 2012: 44 (15): 754–763.”
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607 · cited 8×
“Antioxid Redox Signal 2014: 21 (1): 17–32.”
BackgroundInfluentialMolecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478
Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis
Thimmulappa, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25790 · Cited by 1,028 · cited 1×
“Transcription of Nrf2 can be increased by proinflammatory mediators by the Nf-κB binding site in the Nrf2 gene (30), and there is extensive evidence of crosstalk between the Keap1-Nrf2-ARE and IKKβ-Nf-κB pathways (28, 31), generally indicating that Nrf2 has an opposing effect on the Nf-κB pathway (32).”
BackgroundClements, C. M., McNally, R. S., Conti, B. J., Mak, T. W., & Ting, J. P.-Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607260103 · Cited by 818
Stress-activated cap’n’collar transcription factors in aging and human disease
Sykiotis, G. P., & Bohmann, D. (2010) · Science Signaling · doi:10.1126/scisignal.3112re3 · Cited by 776 · cited 4×
“Antioxid Redox Signal 2013: 18 (2): 139–157.”
BackgroundInfluentialSmall Molecule Modulators of Keap1‐ Nrf2‐ ARE Pathway as Potential Preventive and Therapeutic Agents
Magesh, S., Chen, Y., & Hu, L. (2012) · Medicinal Research Reviews · doi:10.1002/med.21257 · Cited by 760 · cited 1×
“a variety of deleterious health effects, including cancer, drug resistance, and atherosclerosis (7, 11, 60) (Table 1).”
BackgroundRole of Melatonin in the Regulation of Human Circadian Rhythms and Sleep
Cajochen, C., Kräuchi, K., & Wirz‐Justice, A. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.00989.x · Cited by 735 · cited 1×
“Because the hormone melatonin, which varies in a daily cycle and controls a variety of human circadian rhythms (84), has been shown to increase Nrf2 activation (82, 85–89), it is probably that the circadian variations described above are related to or mediated by melatonin release by the pineal gland.”
BackgroundBrusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Ren, D., Villeneuve, N. F., Jiang, T., Wu, T., Lau, A., Toppin, H. A., & Zhang, D. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014275108 · Cited by 673
Cited by
Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
Oh, Y., & Jun, H.-S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010026 · Cited by 217
Zhu, B., Tang, L., Chen, S., Yin, C., Peng, S., Li, X., Liu, T., Liu, W., Han, C., Stawski, L., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0314-0 · Cited by 117
Wang, X., Campbell, M. R., Lacher, S. E., Cho, H.-Y., Wan, M., Crowl, C. L., Chorley, B. N., Bond, G. L., Kleeberger, S. R., Slattery, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.068 · Cited by 49
“…mouse model studies implicate Nrf2 as a susceptibility factor in a broad range of oxidative stress-related pathologies (Cho and Kleeberger, 2015; Hybertson and Gao, 2014; Johnson and Johnson, 2015), suggesting that SNPs affecting human functional NRF2 binding sites (e.g. AREs) could affect risk…”
BackgroundInfluentialNovel Assay To Characterize Neutrophil Responses to Oral Biofilms
Oveisi, M., Shifman, H., Fine, N., Sun, C., Glogauer, N., Senadheera, D., & Glogauer, M. (2019) · Infection and Immunity · doi:10.1128/iai.00790-18 · Cited by 30
Metadata
- Authors
- Hybertson, B. M., & Gao, B.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2014-09-16
- Volume
- 86
- Issue
- 5
- Pages
- 447-452
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W1583684776
- Cited by
- 54
- References
- 15
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of the Nrf2 signaling system in health and disease. https://app.cochat.ai/papers/10.1111/cge.12474
- The paper
- Hybertson, B. M., & Gao, B. (2014). Role of the Nrf2 signaling system in health and disease. Clinical Genetics. https://doi.org/10.1111/cge.12474
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.